← Back
$RYTM All transactions

RHYTHM PHARMACEUTICALS, INC.

F

$ Value

$1.0M

Shares

9,237

Price

$109

Filed

Feb 3

Insider

Name

Lee Jennifer Kayden

Title

EVP, Head of North America

CIK

0001801372

Roles

Officer

Transaction Details

Transaction Date

2026-02-01

Code

F

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

19,233

Footnotes

Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. | These shares were withheld for payment of the withholding taxes upon the vesting of the restricted stock units reported herein. | The restricted stock units vest as to 25% of the total shares on each of February 9, 2023, February 9, 2024, February 9, 2025 and February 1, 2026. The restricted stock units have no expiration date. | The restricted stock units vest as to 25% of the total shares on each of February 1, 2024, February 1, 2025, February 1, 2026 and February 1, 2027. The restricted stock units have no expiration date. | The restricted stock units vest as to 25% of the total shares on each of February 16, 2025, February 1, 2026, February 1, 2027 and February 1, 2028. The restricted stock units have no expiration date. | The restricted stock units vest as to 25% of the total shares on each of February 1, 2026, February 1, 2027, February 1, 2028 and February 1, 2029. The restricted stock units have no expiration date.

Filing Info

Accession No.

0001104659-26-009767

Form Type

4

Issuer CIK

0001649904

Lee Jennifer Kayden's History

Date Ticker Type Value
2026-02-11 RYTM A $0
2026-02-11 RYTM A $0
2026-02-01 RYTM M
2026-02-01 RYTM F $1.0M
2026-02-01 RYTM M $0
2026-02-01 RYTM M $0
2026-02-01 RYTM M $0
2026-02-01 RYTM M $0

Other Insiders at RYTM (90d)

Insider Bought Sold Last
German Christopher Paul
Corporate Controller & CAO
2026-02-11
Popovits Kimberly J 2026-04-01
Meeker David P
President and CEO
2026-02-11
Smith Hunter C
Chief Financial Officer
$2.2M 2026-02-19
Mazabraud Yann
EVP, Head of International
2026-04-01
Lee Jennifer Kayden
EVP, Head of North America
2026-02-11
Cramer Pamela J.
Chief Human Resources Officer
2026-02-11
Shulman Joseph
Chief Technical Officer
2026-02-11
Garfield Alastair
Chief Scientific Officer
2026-02-11